Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement.
about
Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrumentMyasthenia gravisTreatment for Lambert-Eaton myasthenic syndromeTreatment for Lambert-Eaton myasthenic syndromeLong-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.Recommendations of the Neurolaryngology Study Group on laryngeal electromyography.Repetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups.Voltage gated calcium channel antibody-related neurological diseasesAssociation of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.The European LEMS Registry: Baseline Demographics and Treatment ApproachesThe association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit.New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis.Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature.Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients.Patients with ocular symptoms referred for electrodiagnosis: how many of them suffer from myasthenia gravis?Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports.Characteristics of late-onset myasthenia gravis.Concentric needle single fiber electromyography: normative jitter values on voluntary activated Extensor Digitorum Communis.Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.Pure ocular anti-musk myasthenia under no immunosuppressive treatment.
P2860
Q21131900-59C2CAA9-2035-4C80-A8B2-55584CCBE2CFQ21202960-C43EBDF2-525B-4292-90C8-14D1089A8D85Q24234103-95538C50-B896-4E53-8B17-F11599FD2B78Q24246913-4AE3B7BE-FA91-417E-B180-3BAAE0DC0A66Q30316646-907A9FB4-0773-45B9-842E-D6B93C474758Q30481340-B058F5CE-ABB8-4331-9FF7-86B993077DBAQ34026134-E06425F9-0C5B-413D-B33B-FE3CDEA8AE77Q35179343-9195D949-897E-4627-A4AE-CC18CC64DBC2Q36326622-57BDBBE7-4833-4003-B7FB-E957A715095FQ36389693-F07E6BB3-8422-4942-BF0A-BCF97513FA82Q37054967-9C2D43CE-D5A7-40D6-9F23-A13CB1AB2DBEQ37803410-12E14232-E0AF-4BDA-9279-2003B1B78FE4Q38154111-FBCC1DED-33C4-4FBF-8011-56D545032B13Q38291305-E63C37E4-E4A0-4709-96D3-B4BF88428F83Q38537442-6A36026B-229A-4A78-A402-9C4CFFAFDA4DQ39368677-9693F234-E7A2-43EE-9214-0AA96EBDF420Q39760999-7E52315F-B108-41C9-A989-7C17CF514FCFQ41141662-97A0977E-D93D-4249-95C2-BF02F200DB0FQ42090297-6CB9A1AC-A1B3-4FB5-A6CD-36A7B05450C1Q48703896-665530DA-07C2-4C69-A76F-0E4CDCC9DC90Q50947677-25B8EF77-6A53-4404-90FC-5A53047B6F13Q51584920-2E2C6FFD-E7C5-4D92-A0B0-36FE3FB6F89EQ54442969-C6FD42FC-F7B1-49E4-ADE6-4C92746A990C
P2860
Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Practice parameter for repetit ...... c syndrome: summary statement.
@ast
Practice parameter for repetit ...... c syndrome: summary statement.
@en
type
label
Practice parameter for repetit ...... c syndrome: summary statement.
@ast
Practice parameter for repetit ...... c syndrome: summary statement.
@en
prefLabel
Practice parameter for repetit ...... c syndrome: summary statement.
@ast
Practice parameter for repetit ...... c syndrome: summary statement.
@en
P356
P1433
P1476
Practice parameter for repetit ...... c syndrome: summary statement.
@en
P2093
AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine
P304
P356
10.1002/MUS.1139
P577
2001-09-01T00:00:00Z